319 Million SpaceX Shares Unlock Today… And Retail Is Buying the Flood
SpaceX drops another wave of insider stock today.
The company's second lockup tranche frees up to 319 million shares. At Tuesday's close near $143, that's roughly $46 billion worth of stock that insiders can now sell.
And retail investors are lining up to buy it.
Let me explain.
When SpaceX went public on June 12, it priced at $135 and raised roughly $86 billion. The stock surged past $225 in week one. But SpaceX didn't use a normal lockup. Most IPOs free all insider shares after 180 days. SpaceX built seventeen staggered tranches instead… each one dropping a fresh batch of stock over more than a year.
The first wave hit on August 6. It was enormous — up to 911.5 million shares, worth about $101 billion.
Bears were loaded up.
Then? SPCX rose about 6% that day. The feared flood of selling didn't show up. The stock clawed back above its $135 IPO price within the following weeks.
That's the backdrop for today.
This tranche is smaller. But the path ahead is packed. Another roughly 319 million shares free up September 9. An affiliate block drops September 10. Then roughly 328 million on each of September 24, October 9, and October 24. The full 180-day lockup expires December 8.
In other words, billions more shares become tradeable between now and Christmas.
I know what you're thinking. "If the first tranche didn't hurt the stock, why should this one?"
Because of who holds these shares. A relatively small group of long-term holders controls the bulk of the float. Alphabet has held a stake since 2015, back when it invested alongside Fidelity. Other long-time backers, including early venture investors and large institutional funds, sit on positions that go back years, not months.
That's patient capital. But even patient capital has a price.
SPCX trades at $143 — down more than a third from its $225 peak. Wall Street's mood has been broadly upbeat, with some analysts framing the August dip as a buying opportunity. But the sell side isn't unanimous. At least one bank has already come out with a Sell rating and a fair value near $100, warning that the capital SpaceX needs to fund its future businesses makes today's price hard to justify.
So you have a real split. Bulls who see a beaten-down stock with a strong first quarter behind it. And bears who see a supply wall that won't quit until December, with real disagreement over whether the price already reflects it.
Sound familiar? Facebook went through a similar lockup gauntlet in 2012. The stock fell roughly 50% after its IPO… then ground higher as each tranche expired and long-term holders refused to sell.
SpaceX just passed test one. Sixteen more to go.
Where should you invest $100 right now?
Elon Musk just invented and patented this new AI technology…
And he's predicting it will launch a NEW industry that will grow more than 7 million percent in the coming years.
Even if he's only 10% right, that would still be enough to grow $100 into more than $700,000.
This Isn't One Lockup. It's Seventeen.
The schedule is the story. Six of the seventeen tranches are keyed to SpaceX's own earnings dates rather than fixed calendar days, which means the pace of new supply can shift depending on when results land. One conditional tranche, worth close to 456 million shares, only unlocked early if the stock closed 30% above the IPO price on enough sessions before earnings. It didn't come close, so those shares rolled forward into the December 8 expiry instead, making that date even bigger than originally planned. Watch the fine print on each future date, not just the headline number.
Not Every Analyst Is Cheering This Time
A split forming in real time. Coverage on this second tranche has been more mixed than the first. At least one bank initiated coverage with a Sell rating and a fair value roughly 30% below today's price, citing the sheer capital SpaceX needs to fund newer bets like AI compute alongside its core rocket and satellite business. Other desks have stayed constructive, treating the earlier dip as an entry point. That kind of split, rather than one-sided cheerleading, is often a healthier sign for a stock working through a supply overhang. Watch which view gains ground as more tranches land.
New Shares Are Entering the Float From a Different Direction Too
Supply isn't only coming from unlocks. When SpaceX closed its roughly $60 billion all-stock acquisition of the AI coding startup Cursor earlier this month, it issued hundreds of millions of new Class A shares to fund the deal. Those are freshly created shares, not previously locked ones, and when they become tradable depends on separate resale registration rules rather than the lockup calendar. It's a second, quieter source of future float that sits alongside the tranche schedule. Watch for updates on when those shares clear for resale.
The Real Stress Test Is Still Two Milestones Away
Today's tranche is a warm-up. The two dates that matter most are still ahead.
Here's why. The next scheduled releases, in mid-to-late September and October, are each smaller, calendar-based tranches similar in size to today's. The market has now absorbed two of these without serious damage. That builds a track record, but it doesn't prove much about the big ones still to come.
The first real test lands around SpaceX's third-quarter earnings, expected in early November. That release is the largest single tranche of the entire schedule, by far, easily eclipsing everything unlocked so far combined. Unlike the smaller calendar tranches, this one lands right after a fresh earnings report, so the market gets new fundamental information and a wave of new supply at almost the same moment.
The second test is December 8, when the full 180-day lockup period closes entirely, and the shares that missed their price-trigger bonus finally join the float too.
Why should you care about the gap between now and then? Because every calendar tranche the market absorbs calmly makes the case that insiders aren't rushing to cash out. But the November and December releases are large enough that even patient holders selling a modest slice could meaningfully outweigh anything seen so far.
So don't read too much into today holding steady. The real verdict on this lockup arrives in November and December, not August.
Why Spreading Out a Lockup Is Supposed to Calm the Market
Let's keep this simple.
Picture a dam holding back a reservoir. Open every gate on the same day, and the river below floods all at once. Open one gate at a time, on a schedule, and the same total water flows out without ever overwhelming the riverbanks.
A stock lockup works the same way.
In a normal IPO, nearly all insider shares unlock on one single day, usually 180 days after going public. Every early investor and employee can sell at once. If a large chunk decides to cash out together, the sudden flood of new shares can overwhelm demand and push the price down hard, purely from an imbalance of buyers and sellers.
Staggering the release, the way SpaceX has done here, is meant to prevent that flood. Instead of one gate opening all the way, it's several smaller gates opening on a schedule stretched across many months. Each individual release is small enough that ordinary buying can absorb it without much strain.
But here's the part that matters for figuring out what today's calm actually proves. A staggered schedule doesn't eliminate the total amount of stock that eventually hits the market. It just slows down how fast it arrives. Every share that would have unlocked on day 180 in a normal IPO still shows up eventually here too, just spread across seventeen different dates instead of one.
So calm behavior on a small tranche tells you demand can handle a small flow. It doesn't yet tell you demand can handle the biggest gates, the ones tied to earnings and the final expiry, opening later on.
Follow the size of each gate, not just whether the river stayed calm so far.
Remember: a staggered lockup slows the flood, it doesn't shrink it. Calm reactions to small tranches are encouraging, but they don't prove the market can absorb the largest releases still to come. Watch the size of each remaining gate, especially the ones tied to earnings and the final expiry.

